Thousands of boxes of blood circulation medicine recalled in France
Traces of prescription chest pain medicine were found in faulty batch
The medicine is also used to treat haemorrhoids
Cristian Storto/Shutterstock
Around 13,000 boxes of Daflon, a haemorrhoid and blood circulation medicine, have been recalled in France due to production defects.
The recall was announced by France’s Medicine Safety Agency (L'Agence nationale de sécurité du médicament, ANSM) yesterday (August 12).
“Traces of trimétazidine, a prescription drug used for angina pectoris [chest pain] in adults,” had been detected in the batch, it announced in a press release.
The recall affects boxes of Daflon 500 mg, with the lot number 6068122. Other batches are unaffected.
The medicine can be bought over the counter, and does not require a prescription.
Patients who have a box of the affected drug should return it to their pharmacist, who will exchange it for a batch that has not been compromised.
If you are unsure if your box is impacted, you can take it to your pharmacist, who will advise you.
If your pharmacist cannot immediately replace the medication, the ANSM says it is okay for the treatment to be temporarily interrupted, and this will not negatively affect the patient.
“According to the analyses carried out by the laboratory on this batch, the very small quantities of trimétazidine found do not present a risk for patients who may have been exposed to them,” the ANSM said.
Nobody who took a compromised batch of the medicine has required additional medical care, it added.
Read more: Seven medicines used in France withdrawn over irregularities
